Disease Progression of Idiopathic Cervical Dystonia in Spite of Improvement After Botulinum Toxin Therapy

Aim of the Study: To demonstrate general progression of symptoms in cervical dystonia (CD) on the one hand and improvement of some special symptoms on the other hand after botulinum toxin (BoNT) therapy.Methods: 74 patients with idiopathic CD under continuous treatment in a BoNT outpatient departmen...

Full description

Bibliographic Details
Main Authors: Harald Hefter, Isabelle Schomaecker, Max Schomaecker, Sara Samadzadeh
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2020.588395/full
_version_ 1818414571196514304
author Harald Hefter
Isabelle Schomaecker
Max Schomaecker
Sara Samadzadeh
author_facet Harald Hefter
Isabelle Schomaecker
Max Schomaecker
Sara Samadzadeh
author_sort Harald Hefter
collection DOAJ
description Aim of the Study: To demonstrate general progression of symptoms in cervical dystonia (CD) on the one hand and improvement of some special symptoms on the other hand after botulinum toxin (BoNT) therapy.Methods: 74 patients with idiopathic CD under continuous treatment in a BoNT outpatient department with at least three injections, completed a short questionnaire. They were asked whether pain, increased muscle tone and tension, reduced mobility of the head, abnormal head position, head tremor, or other symptoms had been present at the onset of BoNT-therapy and which symptoms were present at the time of recruitment. Patients had to rate actual severity of CD in percent of the severity of CD at the onset of BoNT-therapy. The TSUI score was determined by the treating physician. Blood samples were taken to analyze induction of neutralizing antibodies.Results: Mean improvement of CD reported by the patients and scored by the physician was about 50%. The frequency of all symptoms increased with duration of therapy. The symptom most frequently improved was abnormal head position. The longer the time span between onset of symptoms and onset of BoNT-therapy was, the higher was the actual TSUI score and the lower the improvement reported. Twelve patients had positive antibody tests.Conclusions: Patients experience a progression of CD, but recognize improvement of abnormal head position due to BoNT-therapy. The longer patients have been without BoNT- therapy, the poorer is the long-term outcome independent on duration of BoNT treatment. Therefore BoNT-therapy should be initiated as early as possible.
first_indexed 2024-12-14T11:21:13Z
format Article
id doaj.art-b343c2b83916473f92072632a951f011
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-12-14T11:21:13Z
publishDate 2020-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-b343c2b83916473f92072632a951f0112022-12-21T23:03:45ZengFrontiers Media S.A.Frontiers in Neurology1664-22952020-11-011110.3389/fneur.2020.588395588395Disease Progression of Idiopathic Cervical Dystonia in Spite of Improvement After Botulinum Toxin TherapyHarald HefterIsabelle SchomaeckerMax SchomaeckerSara SamadzadehAim of the Study: To demonstrate general progression of symptoms in cervical dystonia (CD) on the one hand and improvement of some special symptoms on the other hand after botulinum toxin (BoNT) therapy.Methods: 74 patients with idiopathic CD under continuous treatment in a BoNT outpatient department with at least three injections, completed a short questionnaire. They were asked whether pain, increased muscle tone and tension, reduced mobility of the head, abnormal head position, head tremor, or other symptoms had been present at the onset of BoNT-therapy and which symptoms were present at the time of recruitment. Patients had to rate actual severity of CD in percent of the severity of CD at the onset of BoNT-therapy. The TSUI score was determined by the treating physician. Blood samples were taken to analyze induction of neutralizing antibodies.Results: Mean improvement of CD reported by the patients and scored by the physician was about 50%. The frequency of all symptoms increased with duration of therapy. The symptom most frequently improved was abnormal head position. The longer the time span between onset of symptoms and onset of BoNT-therapy was, the higher was the actual TSUI score and the lower the improvement reported. Twelve patients had positive antibody tests.Conclusions: Patients experience a progression of CD, but recognize improvement of abnormal head position due to BoNT-therapy. The longer patients have been without BoNT- therapy, the poorer is the long-term outcome independent on duration of BoNT treatment. Therefore BoNT-therapy should be initiated as early as possible.https://www.frontiersin.org/articles/10.3389/fneur.2020.588395/fullcervical dystonianatural historyprogression of CDbotulinum toxin therapylong-term outcomesecondary treatment failure
spellingShingle Harald Hefter
Isabelle Schomaecker
Max Schomaecker
Sara Samadzadeh
Disease Progression of Idiopathic Cervical Dystonia in Spite of Improvement After Botulinum Toxin Therapy
Frontiers in Neurology
cervical dystonia
natural history
progression of CD
botulinum toxin therapy
long-term outcome
secondary treatment failure
title Disease Progression of Idiopathic Cervical Dystonia in Spite of Improvement After Botulinum Toxin Therapy
title_full Disease Progression of Idiopathic Cervical Dystonia in Spite of Improvement After Botulinum Toxin Therapy
title_fullStr Disease Progression of Idiopathic Cervical Dystonia in Spite of Improvement After Botulinum Toxin Therapy
title_full_unstemmed Disease Progression of Idiopathic Cervical Dystonia in Spite of Improvement After Botulinum Toxin Therapy
title_short Disease Progression of Idiopathic Cervical Dystonia in Spite of Improvement After Botulinum Toxin Therapy
title_sort disease progression of idiopathic cervical dystonia in spite of improvement after botulinum toxin therapy
topic cervical dystonia
natural history
progression of CD
botulinum toxin therapy
long-term outcome
secondary treatment failure
url https://www.frontiersin.org/articles/10.3389/fneur.2020.588395/full
work_keys_str_mv AT haraldhefter diseaseprogressionofidiopathiccervicaldystoniainspiteofimprovementafterbotulinumtoxintherapy
AT isabelleschomaecker diseaseprogressionofidiopathiccervicaldystoniainspiteofimprovementafterbotulinumtoxintherapy
AT maxschomaecker diseaseprogressionofidiopathiccervicaldystoniainspiteofimprovementafterbotulinumtoxintherapy
AT sarasamadzadeh diseaseprogressionofidiopathiccervicaldystoniainspiteofimprovementafterbotulinumtoxintherapy